Company intelligence / Profile preview

On-chip Biotechnologies

Koganei-shi, Tokyo, Japanon-chipbio.com ↗

Ownership: Private
Employees: ~33
Development stage: Commercial

Overview

The company has successfully commercialized multiple products including On-chip Sort (2012) and On-chip Droplet Selector (2022). They received the "Small and Medium Enterprise Director-General's Award" in April 2024.

Modalities: Cell sorting technologyMicrofluidic technology
Industry: Non-Drug Biotech

Partnerships

PHC Corporation of North America

Beyond the preview

Go deeper on On-chip Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on On-chip Biotechnologies.

Explore the full profile